SCHEMBL2736608

SCHEMBL2736608

Cn1cc(C(=O)NCc2ccccc2)ccc1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
BRD4 O60885 2/20 0.58
HDAC6 Q9UBN7 3/20 0.58
HDAC2 Q92769 1/20 0.58
HDAC8 Q9BY41 1/20 0.58
LMNA P02545 1/20 0.57
RAB9A P51151 1/20 0.57
HPGD P15428 2/20 0.55
HDAC1 Q13547 2/20 0.54
TSHR P16473 2/20 0.54
POLB P06746 2/20 0.54
KDM4E B2RXH2 1/20 0.54
RECQL P46063 1/20 0.54
KMT2A Q03164 2/20 0.53
MEN1 O00255 1/20 0.53
GAA P10253 1/20 0.53
APOBEC3A P31941 1/20 0.52
CTDSP1 Q9GZU7 1/20 0.52
APOBEC3G Q9HC16 1/20 0.52
BRD2 P25440 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2760209 0.81 BRD4 (0.55) ALDH1A1BRD4HDAC6HDAC2HDAC8
SCHEMBL15224261 0.81 CREBBP (0.50) ALDH1A1BRD4LMNARAB9AHPGD
SCHEMBL11900090 0.80 HDAC6 (0.85) HDAC6HDAC2HDAC8LMNARAB9A
SCHEMBL6533268 0.78 LMNA (0.48) ALDH1A1BRD4LMNAHPGDPOLB
SCHEMBL2896747 0.77 CREBBP (0.52) ALDH1A1BRD4LMNARAB9AHPGD
SCHEMBL457082 0.76 HDAC6 (0.79) ALDH1A1HDAC6HDAC2HDAC8LMNA
SCHEMBL16589429 0.76 HDAC6 (0.72) ALDH1A1HDAC6HDAC2HDAC8LMNA
SCHEMBL178366 0.76 MAPK14 (0.75) ALDH1A1HDAC6HDAC2HDAC8LMNA
SCHEMBL29315584 0.75 ALDH1A1 (0.68) ALDH1A1HDAC6HDAC2HDAC8LMNA
SCHEMBL4747957 0.75 NR1H4 (0.81) HDAC6HDAC2HDAC8LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088924-B2 Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor SHIONOGI & CO., LTD. (JP) 2012-01-03 US disclosed
US-20100081686-A1 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter TADA YUKIO 2010-04-01 US disclosed
US-20080312292-A1 Antipruritics YASUI KIYOSHI 2008-12-18 US disclosed
US-20070027144-A1 Novel use of cannabinoid receptor agonist SHIONOGI & CO., LTD. (JP) 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027144-A1 Novel use of cannabinoid receptor agonist CNR2, CNR1, OPRM1 ALDH1A1 2784/4885BRD4 363/4885HDAC6 2514/4885
US-20100081686-A1 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter CNR2, CNR1, NPY2R ALDH1A1 3078/4885BRD4 152/4885HDAC6 4752/4885
US-20080312292-A1 Antipruritics CNR1, CNR2, OPRL1 ALDH1A1 3580/4885BRD4 446/4885HDAC6 918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.